ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
NKGen Biotech Inc

NKGen Biotech Inc (NKGN)

1.2395
0.0495
( 4.16% )
Updated: 13:35:26

NKGen Biotech Inc Financial Summary

The current NKGN market cap is 27.13M. The company's latest EPS is USD -3.7898 and P/E is -0.32.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -955k-2.68M-16.78M-12.76M-7.62M
Net Income 379k-1.83M-47.9M-33.61M-5.38M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -2.51M-2.74M-33.08M
Net Income -991k4.55M-82.95M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)
Total Assets 175.68M63.61M25.2M16.48M16.32M
Total Liabilities 6.29M9.35M65.84M75.17M71.37M
Total Equity -5.3M-8.54M-40.64M-58.69M-55.06M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 174.19M174.37M16.48M
Total Liabilities 13.47M5.37M75.17M
Total Equity -10.9M-4.17M-58.69M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)
Operating -509k-1.06M-15.01M-21.95M-4.03M
Investing 81k113.35M-30k-48k35k
Financing N/A -112.88M23.96M22.16M4.01M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -1.53M-1.57M-21.95M
Investing -171.62M569k-48k
Financing 174.86M-85k22.16M
Market Cap 27.13M
Price to Earnings Ratio -0.32
Price to Sales Ratio 0
Price to Cash Ratio 1.03k
Price to Book Ratio -0.46
Dividend Yield -

Share Statistics

Shares Outstanding 21.89M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (0.81%)

Company Info

Company Name NKGen Biotech Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://nkgenbiotech.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock